Cart
sales@molnova.com
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
CAS No. 55483-24-4
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid ( )
Catalog No. M31919 CAS No. 55483-24-4
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 630 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product Nameent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
-
NoteResearch use only, not for human use.
-
Brief Descriptionent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
-
Descriptionent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55483-24-4
-
Formula Weight334.5
-
Molecular FormulaC20H30O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DCAI
DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
-
Anavenol
Anavenol is an equine anesthetic.
-
PAT-1251
PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
